Frequently Asked Questions
The market is segmented based on Asia-Pacific Infusion Pumps Market, By Type (Traditional Infusion Pumps, Specialty Infusion Pumps), Accessories and Consumables (Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps, Infusion Catheters, IV/Administration Sets, Needleless Connectors, Cannulas, Tubing and Extension Sets, Valves, Others), Application (Hemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Paediatrics/Neonatology, Haematology, Other), End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes) – Industry Trends and Forecast to 2030.
.
The Asia Pacific Infusion Pumps Market size was valued at USD 4.40 USD Billion in 2022.
The Asia Pacific Infusion Pumps Market is projected to grow at a CAGR of 4.9% during the forecast period of 2023 to 2030.
The major players operating in the market include , BD , B. Braun Melsungen AG , Baxter , Fresenius Kabi AG , ICU Medical , Smiths Group PLC , Medtronic , Moog , Terumo Corporation , Avanos Corporate , NIPRO , Insulet Corporation , Tandem Diabetes Care , JMS Co. , F. Hoffmann,La Roche ,.
The market report covers data from the Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific.
